GGrantIndex
Sort

172,184 grants matching inflammation

Epithelial Genes in Allergic Inflammation

$1,389,901
Gurjit K Khurana Hershey · Cincinnati Childrens Hosp Med Ctr · U19 · FY2014 · AI

Epithelial Genes in Allergic Inflammation

$1,389,901
Gurjit K Khurana Hershey · Cincinnati Childrens Hosp Med Ctr · U19 · FY2015 · AI

Core E: Proteomics Core

$1,389,579
Richard D Smith · Massachusetts General Hospital · U54 · FY2009 · GM

A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV)

$1,389,503
Christine Marie Durand · Johns Hopkins University · U01 · FY2023 · AI

PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study

$1,389,219
Christine M Albert · Brigham And Women'S Hospital · R01 · FY2010 · HL

Alzheimer’s Disease Related Biomarkers following SARS-CoV-2 Infection

$1,389,203
Thomas M Wisniewski · New York University School Of Medicine · R01 · FY2024 · AG

Alzheimer’s Disease Related Biomarkers following SARS-CoV-2 Infection

$1,389,203
Thomas M Wisniewski · New York University School Of Medicine · R01 · FY2023 · AG

Cerebral Vascular Biology Program Project Grant

$1,389,099
University Of Iowa · P01 · FY2005 · NS

p53 - Regulators and Effectors

$1,388,997
Stuart A Aaronson · Icahn School Of Medicine At Mount Sinai · P01 · FY2009 · CA

RESEARCH DIAGNOSTIC CRITERIA-- RELIABILITY AND VALIDITY

$1,388,868
University Of Minnesota Twin Cities · U01 · FY2003 · DE

San Francisco Bay Clinical Trials Unit

$1,388,627
Susan Buchbinder · Public Health Foundation Enterprises · UM1 · FY2016 · AI

A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV)

$1,388,200
Christine Marie Durand · Johns Hopkins University · U01 · FY2024 · AI

Vancouver Drug Users Study: The Impacts of Evolving Drug Use Patterns on HIV/AIDS

$1,388,180
Kanna Hayashi · Simon Fraser University · U01 · FY2020 · DA

From therapeutic mechanisms to unraveling the pathophysiology of MS

$1,388,137
Bibiana Bielekova · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

ADP-ribosylation Cycles

$1,388,014
Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL

Cellular & Inflammatory Pathways in Ashtma & Allergic Diseases: From IgE to Cells

$1,387,837
Lawrence Barry Schwartz · Virginia Commonwealth University · U19 · FY2008 · AI

Discovery of adjuvants via novel modulation of innate immune pathways for vaccines against influenza

$1,387,684
Aaron Esser-Kahn · University Of Chicago · N01 · FY2022 · AI

Saturated Fat and Protein Effects on Atherogenic Dyslipidemia

$1,387,413
Ronald M Krauss · Children'S Hospital & Res Ctr At Oakland · R01 · FY2015 · HL

MODULATION OF EFFECTOR T CELLS IN DIABETES

$1,387,317
Scripps Research Institute · P01 · FY2004 · DK

MODULATION OF EFFECTOR T CELLS IN DIABETES

$1,387,317
Scripps Research Institute · P01 · FY2002 · DK

MODULATION OF EFFECTOR T CELLS IN DIABETES

$1,387,317
Scripps Research Institute · P01 · FY2003 · DK

Extracranial Carotid Atherosclerosis Contributions to Cognitive Impairment and Alzheimer's Disease Risk

$1,387,313
Craig C Weinkauf · University Of Arizona · R01 · FY2024 · AG

Pulmonary Effects of Environmental Oxidant Pollutants

$1,387,039
Charles G. Plopper · University Of California At Davis · P01 · FY2006 · ES

Lung Endothelial Cell Phenotypes

$1,386,809
University Of South Alabama · P01 · FY2005 · HL

Helicobacter pylori Pathogenesis Studies

$1,386,563
William Coleman · National Institute On Minority Health And Health Disparities · ZIA · FY2014 · MD